Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate |
2003-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2006-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2006508123-A |
titleOfInvention |
Celecoxib prodrug |
abstract |
N-[[4- [5- (4-Methylphenyl) -3- (trifluoromethyl) -1H-pyrazol-1-yl] phenyl] sulfonyl] propanamide and its pharmaceutically acceptable salts are selective COX -2 A useful prodrug of the inhibitory drug celecoxib and can be administered to patients by any suitable route. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006517527-A |
priorityDate |
2002-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |